Physician profile
Anuj Suri
NPI 1326366691
$72,479.12
in general payments reported to CMS, 2019-2025
45 companies · $17K in 2025
The $17K reported for 2025 was more than what 93% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,945 · 2021: $8,781 · 2022: $12K · 2023: $10K · 2024: $9,517 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Consulting Fee: $9,120 · Honoraria: $8,860 · Food and Beverage: $3,751 · Travel and Lodging: $2,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,244.00 |
| Consulting Fee | $9,120.00 |
| Honoraria | $8,860.00 |
| Food and Beverage | $3,751.09 |
| Travel and Lodging | $2,615.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $48,130.06 | 2019-2025 | Exparel, Iovera, Zilretta |
| Intuitive Surgical, INC. | $13,217.42 | 2023-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $4,808.59 | 2020-2025 | Floseal, Perclot, Tisseel |
| Ethicon INC. | $2,020.00 | 2022 | |
| Merck Sharp & Dohme LLC | $423.49 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Glaxosmithkline, LLC. | $386.04 | 2020-2025 | Zejula, Jemperli |
| Myriad Genetic Laboratories, INC. | $375.27 | 2021-2024 | Myrisk, Precisetumor |
| Bayer Healthcare Pharmaceuticals INC. | $367.84 | 2019-2023 | |
| Eisai INC. | $277.47 | 2019-2025 | |
| Astellas Pharma US INC | $250.74 | 2022-2024 | Veozah, Cresemba |
| Davol INC. | $212.88 | 2022-2025 | Arista Ah Flexitip, Arista |
| Dilon Technologies, INC. | $195.82 | 2025 | Hemoblast Bellows |
| Myovant Sciences INC. | $176.71 | 2021-2022 | |
| Abbvie INC. | $167.49 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Duchesnay USA Incorporated | $121.36 | 2019 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $115.28 | 2019-2024 | |
| Daiichi Sankyo INC. | $101.97 | 2021-2023 | Injectafer |
| Therapeuticsmd, INC. | $101.59 | 2019-2022 | |
| Tesaro, INC. | $89.85 | 2019 | |
| Mayne Pharma Commercial LLC | $80.57 | 2022-2023 | |
| Scynexis, INC. | $77.27 | 2022 | |
| Sumitomo Pharma America, INC. | $76.69 | 2023-2025 | Myfembree |
| Aspira Women'S Health INC | $68.27 | 2019-2024 | Ova1 |
| Ethicon US, LLC | $64.17 | 2020-2022 | |
| Genmab U.S., INC. | $60.45 | 2024-2025 | Tivdak |
| Clovis Oncology, INC. | $52.45 | 2019 | |
| Organon LLC | $50.54 | 2022-2023 | Nexplanon |
| Smith+Nephew, INC. | $49.12 | 2023 | Stravix Pl |
| Caris Mpi, INC. | $41.88 | 2025 | Mi Cancer Seek |
| Baudax Bio INC. | $39.30 | 2021 | |
| Integra Lifesciences Corporation | $37.34 | 2023 | Duraseal Exact Spinal Sealant System, Codman Hakim, Cusa Clarity |
| Medtronic, INC. | $26.86 | 2022 | |
| Medical Device Business Services, INC. | $24.39 | 2025 | Enseal |
| Alexion Pharmaceuticals, INC. | $22.99 | 2022 | |
| Biom'Up Sa | $19.47 | 2019 | |
| Sanara Medtech INC. | $17.16 | 2021 | |
| Amag Pharmaceuticals, INC. | $15.50 | 2019 | |
| Hologic Sales and Service, LLC | $15.40 | 2023 | Affirm Prone Biopsy System |
| Millicent US INC | $15.28 | 2024 | Femring, Intrarosa |
| Evofem Biosciences, INC. | $15.24 | 2022 | |
| Coopersurgical, INC. | $14.90 | 2022 | |
| Meditrina | $14.58 | 2024 | |
| Kci USA, INC. | $14.29 | 2020 | |
| Novo Nordisk INC | $13.02 | 2019 | |
| Lupin INC. | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Suri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.